An Astroglial Basis of Major Depressive Disorder: Molecular, Cellular, and Circuit Features

被引:4
|
作者
Lu, Cheng-Lin [1 ,2 ]
Ren, Jing [1 ]
Cao, Xiong [1 ]
机构
[1] Southern Med Univ, Guangdong Hong Kong Macao Greater Bay Area Ctr Bra, Guangdong Basic Res Ctr Excellence Integrated Trad, Sch Basic Med Sci,Key Lab Mental Hlth Minist Educ,, Guangzhou, Peoples R China
[2] Southern Med Univ, Zhujiang Hosp, Microbiome Med Ctr, Dept Lab Med, Guangzhou, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
FIBRILLARY ACIDIC PROTEIN; FIBROBLAST-GROWTH-FACTOR; PREFRONTAL CORTEX; NEUROTROPHIC FACTOR; RAT MODEL; FUNCTIONAL CONNECTIVITY; ASTROCYTE DYSFUNCTION; GLUCOSE-METABOLISM; GLUTAMATE UPTAKE; WHITE-MATTER;
D O I
10.1016/j.biopsych.2024.07.017
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Major depressive disorder is a common psychiatric disorder and a leading cause of disability worldwide. Astrocytes play a role in the maintenance of the function of the central nervous system, both physiologically and pathologically. Accumulated evidence indicates that the astrocyte is an important contributor to the pathophysiology of major depressive disorder including blood-brain barrier integrity, gap junctions, gliotransmission, glutamate homeostasis, and energy metabolism. Here, we comprehensively summarize an astroglial basis for major depressive disorder based on molecular, cellular, and circuit properties, suggesting that astrocytes appear to be highly sensitive to stress and are likely to be uniquely positioned to integrate peripheral and central stress responses.
引用
收藏
页码:217 / 226
页数:10
相关论文
共 50 条
  • [21] Major depressive disorder with anxious features - the role of pregabalin
    Carvalho, R. S.
    Afonso, B. R.
    Santos, E.
    EUROPEAN PSYCHIATRY, 2023, 66 : S843 - S843
  • [22] The clinical characteristics of major depressive disorder with psychotic features
    Kang, M. H.
    Han, S. W.
    Kim, C. E.
    Lee, J. S.
    Bae, J. N.
    Lee, S. Y.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S300 - S300
  • [23] Missed Diagnosis of Major Depressive Disorder with Catatonia Features
    Jhawer, Harry
    Sidhu, Meesha
    Patel, Rikinkumar S.
    BRAIN SCIENCES, 2019, 9 (02)
  • [24] Challenges in the Treatment of Major Depressive Disorder With Psychotic Features
    Rothschild, Anthony J.
    SCHIZOPHRENIA BULLETIN, 2013, 39 (04) : 787 - 796
  • [25] Korean medication algorithm for depressive disorder (II): Major depressive disorder without psychotic features
    Seok, J. H.
    Jon, D. I.
    Min, K. J.
    Bahk, W. M.
    Hong, J. P.
    Lee, S. Y.
    JOURNAL OF AFFECTIVE DISORDERS, 2008, 107 : S90 - S90
  • [26] Hippocampus: Molecular, Cellular, and Circuit Features in Anxiety
    Shi, Hu-Jiang
    Wang, Shuang
    Wang, Xin-Ping
    Zhang, Rui-Xin
    Zhu, Li-Juan
    NEUROSCIENCE BULLETIN, 2023, 39 (06) : 1009 - 1026
  • [27] Lumateperone Treatment for Major Depressive Episodes With Mixed Features in Major Depressive Disorder and Bipolar I or Bipolar II Disorder
    Earley, Willie
    Durgam, Suresh
    Kozauer, Susan G.
    Chen, Changzheng
    Huo, Jason
    Stahl, Stephen
    McIntyre, Roger S.
    NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 198 - 198
  • [28] Hippocampus: Molecular, Cellular, and Circuit Features in Anxiety
    Hu-Jiang Shi
    Shuang Wang
    Xin-Ping Wang
    Rui-Xin Zhang
    Li-Juan Zhu
    Neuroscience Bulletin, 2023, 39 : 1009 - 1026
  • [29] LUMATEPERONE TREATMENT FOR MAJOR DEPRESSIVE EPISODES WITH MIXED FEATURES IN MAJOR DEPRESSIVE DISORDER AND BIPOLAR I OR BIPOLAR II DISORDER
    Bhagwagar, Zubin
    Kozauer, Susan G.
    Earley, Willie R.
    Chen, Changzheng
    Huo, Jason
    Stahl, Stephen
    Mcintyre, Roger S.
    Durgam, Suresh
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2025, 28 : i19 - i19
  • [30] Lumateperone treatment for major depressive episodes with mixed features in major depressive disorder and bipolar I or bipolar II disorder
    Durgam, Suresh
    Kozauer, Susan G.
    Earley, Willie R.
    Chen, Changzheng
    Huo, Jason
    Martin, Margaret
    Stahl, Stephen
    McIntyre, Roger S.
    BIPOLAR DISORDERS, 2024, 26 : 94 - 94